Dahl & Gravesens MurRens og Udlejning ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  16.1% 9.9% 6.7% 8.4% 7.5%  
Credit score (0-100)  11 23 35 28 33  
Credit rating  BB BB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  39.6 146 411 414 388  
EBITDA  39.6 146 411 414 388  
EBIT  21.5 27.2 169 95.9 96.9  
Pre-tax profit (PTP)  18.5 2.5 121.1 31.4 13.3  
Net earnings  13.9 1.9 94.2 24.5 9.4  
Pre-tax profit without non-rec. items  18.5 2.5 121 31.4 13.3  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  54.3 1,100 1,852 1,534 3,479  
Shareholders equity total  78.4 80.3 175 199 208  
Interest-bearing liabilities  0.0 0.0 81.0 82.5 1,719  
Balance sheet total (assets)  101 1,269 2,131 1,696 3,921  

Net Debt  -46.5 -118 26.9 -28.0 1,559  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  39.6 146 411 414 388  
Gross profit growth  -3.7% 269.2% 181.1% 0.7% -6.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  101 1,269 2,131 1,696 3,921  
Balance sheet change%  24.5% 1,159.8% 67.9% -20.4% 131.2%  
Added value  39.6 146.2 411.1 338.2 387.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -36 927 510 -636 1,654  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  54.3% 18.6% 41.0% 23.2% 25.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  23.7% 4.0% 9.9% 5.0% 3.5%  
ROI %  29.8% 34.1% 32.8% 10.5% 5.8%  
ROE %  19.4% 2.5% 74.0% 13.1% 4.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  77.8% 6.3% 8.2% 11.7% 5.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -117.3% -80.6% 6.6% -6.8% 401.9%  
Gearing %  0.0% 0.0% 46.4% 41.5% 824.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 117.4% 79.7% 9.4%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.1 0.1 0.2 0.2 0.1  
Current Ratio  2.1 0.1 0.2 0.2 0.1  
Cash and cash equivalent  46.5 117.9 54.1 110.6 159.7  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  24.8 -1,019.9 -985.6 -718.6 -2,734.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0